Evidence map›Paper›PMID 25093703›Full record

ArticleNeuroscience letters2014

Chronic sleep restriction elevates brain interleukin-1 beta and tumor necrosis factor-alpha and attenuates brain-derived neurotrophic factor expression.

Mark R Zielinski, Youngsoo Kim, Svetlana A Karpova, Robert W McCarley, Robert E Strecker, Dmitry Gerashchenko

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A [Journal of neuroinflammation · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Foods (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mark R ZielinskiDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, West Roxbury, MA 02132, USA. Electronic address: Mark_Zielinski@hms.harvard.edu.
Youngsoo KimDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, Brockton, MA 02301, USA.
Svetlana A KarpovaDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, West Roxbury, MA 02132, USA.
Robert W McCarleyDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, Brockton, MA 02301, USA.
Robert E StreckerDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, Brockton, MA 02301, USA.
Dmitry GerashchenkoDepartment of Psychiatry, Harvard Medical School and Veterans Affairs Boston Healthcare System, West Roxbury, MA 02132, USA.
Harvard University · USVA Boston Healthcare System · US

Funding

Wakefulness and Forebrain Activation by Orexin NeuronsP01HL095491 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLMAN, DAVID ANDREW · 2010 to 2019
$25.1M
VLPO Lesion Induced Sleep Interruption and AdenosineP50HL060292 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROSENBERG, PAUL ALLEN · 1998 to 2007
$15.0M
Stuart T. Hauser Research Training Program in Biological and Social Psychiatry.T32MH016259 · NIMH · JUDGE BAKER CHILDREN'S CENTER · PI Marek Kubicki, Martha E. Shenton · 1985 to 2026
$8.4M
THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR01MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BROWN, RITCHIE EDWARD · 1985 to 2017
$3.8M
THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR37MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MCCARLEY, ROBERT W · 1987 to 2006
$3.1M
Role of cortical interneurons in synchronization of brain electroencephalogramR01NS064193 · NINDS · HARVARD MEDICAL SCHOOL · PI GERASHCHENKO, DMITRY · 2010 to 2013
$1.1M
Sleep loss impairment of arousal and cognition: role of the basal forebrainI01BX002774 · VA · VA BOSTON HEALTH CARE SYSTEM · PI JAMES M MCNALLY · 2016 to 2026
–
BLRD VA I01 BX000270BLRD VA I01 BX002774BLRD VA IK6 BX005714NHLBI NIH HHS HL060292NHLBI NIH HHS HL095491NHLBI NIH HHS P01 HL095491NHLBI NIH HHS P50 HL060292NIMH NIH HHS MH039683NIMH NIH HHS R01 MH039683NIMH NIH HHS R37 MH039683NIMH NIH HHS T32 MH016259NINDS NIH HHS NS064193NINDS NIH HHS R01 NS064193
6 · The paper itself

Abstract

Acute sleep loss increases pro-inflammatory and synaptic plasticity-related molecules in the brain, including interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and brain-derived neurotrophic factor (BDNF). These molecules enhance non-rapid eye movement sleep slow wave activity (SWA), also known as electroencephalogram delta power, and modulate neurocognitive performance. Evidence suggests that chronic sleep restriction (CSR), a condition prevalent in today's society, does not elicit the enhanced SWA that is seen after acute sleep loss, although it cumulatively impairs neurocognitive functioning. Rats were continuously sleep deprived for 18h per day and allowed 6h of ad libitum sleep opportunity for 1 (SR1), 3 (SR3), or 5 (SR5) successive days (i.e., CSR). IL-1β, TNF-α, and BDNF mRNA levels were determined in the somatosensory cortex, frontal cortex, hippocampus, and basal forebrain. Largely, brain IL-1β and TNF-α expression were significantly enhanced throughout CSR. In contrast, BDNF mRNA levels were similar to baseline values in the cortex after 1 day of SR and significantly lower than baseline values in the hippocampus after 5 days of SR. In the basal forebrain, BDNF expression remained elevated throughout the 5 days of CSR, although IL-1β expression was significantly reduced. The chronic elevations of IL-1β and TNF-α and inhibition of BDNF might contribute to the reported lack of SWA responses reported after CSR. Further, the CSR-induced enhancements in brain inflammatory molecules and attenuations in hippocampal BDNF might contribute to neurocognitive and vigilance detriments that occur from CSR.

Indexed as

AnimalsBrainBrain-Derived Neurotrophic FactorCerebral CortexInterleukin-1betaMaleRats, Sprague-DawleyRNA, MessengerSleep DeprivationTumor Necrosis Factor-alphaBrain-Derived Neurotrophic FactorInterleukin-1betaRNA, MessengerTumor Necrosis Factor-alphaBrain-derived neurotropic factorCytokineInterleukin-1 betaSleep deprivationSleep restrictionTumor necrosis factor-alpha

Identifiers

PMID25093703
PMCPMC4162816
OpenAlexW2079660090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.